| |
| Trade Name | PHIL Liquid Embolic System |
| Classification Name | dural arteriovenous fistula liquid embolic |
| Generic Name | dural arteriovenous fistula liquid embolic |
| Applicant |
| MicroVention, Inc. |
| 35 enterprise |
| aliso veijo, CA 92656 |
|
| HDE Number | H240004 |
| Date Received | 10/22/2024 |
| Decision Date | 12/31/2025 |
| Product Code | |
| Docket Number | FDA-0463 |
| Notice Date | 11/16/2026 |
| Advisory Committee |
Neurology |
| Clinical Trials |
NCT03467542
|
| Supplement Type | hde original |
| Expedited Review Granted? | No |
| Combination Product | No |
Approval Order Statement The phil liquid embolic system is indicated for use in the treatment of intracranial dural arteriovenous fistulas (davfs). |
| Approval Order | Approval Order |
| Summary | Summary of Safety And Probable Benefit |
| Labeling | Labeling Labeling Part 2 |